Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Gene Mutations and Epilepsy Drug Responsiveness Study
ChiCTR-OCH-09000813Phase 4Recruiting
- Sponsor
- Central South University
- Start
- Aug 2009
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of carbamazepine and valproic acid in epilepsy (3 arms), sponsored by Central South University. Primary endpoint: Index of function of Liver and Kidney. Started Aug 2009; status: recruiting.
02
Drugs
carbamazepinevalproic acid
03
Conditions
epilepsy
Beyond the preview
Go deeper on ChiCTR-OCH-09000813.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR-OCH-09000813.